Your browser doesn't support javascript.
loading
Heterotypic macrophages/microglia differentially contribute to retinal ischaemia and neovascularisation.
Yamaguchi, Muneo; Nakao, Shintaro; Arima, Mitsuru; Little, Karis; Singh, Aditi; Wada, Iori; Kaizu, Yoshihiro; Zandi, Souska; Garweg, Justus G; Matoba, Tetsuya; Shiraishi, Wataru; Yamasaki, Ryo; Shibata, Kensuke; Go, Yasuhiro; Ishibashi, Tatsuro; Uemura, Akiyoshi; Stitt, Alan W; Sonoda, Koh-Hei.
Afiliação
  • Yamaguchi M; Department of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Nakao S; Department of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. s.nakao.dk@juntendo.ac.jp.
  • Arima M; Department of Ophthalmology, National Hospital Organization, Kyushu Medical Center, Fukuoka, Japan. s.nakao.dk@juntendo.ac.jp.
  • Little K; Clinical Research Institute, National Hospital Organization, Kyushu Medical Center, Fukuoka, Japan. s.nakao.dk@juntendo.ac.jp.
  • Singh A; Department of Ophthalmology, Juntendo University School of Medicine, Tokyo, Japan. s.nakao.dk@juntendo.ac.jp.
  • Wada I; Department of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Kaizu Y; Wellcome Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast, UK.
  • Zandi S; Wellcome Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast, UK.
  • Garweg JG; Department of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Matoba T; Department of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Shiraishi W; Department of Ophthalmology and Department of BioMedical Sciences, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Yamasaki R; Department of Ophthalmology and Department of BioMedical Sciences, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Shibata K; Department of Cardiovascular Medicine, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.
  • Go Y; Department of Neurology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Ishibashi T; Department of Neurology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Uemura A; Department of Biology and Biochemistry, University of Yamaguchi, Ube, Japan.
  • Stitt AW; Cognitive Genomics Research Group, Exploratory Research Center on Life and Living Systems, National Institutes of Natural Sciences, Okazaki, Japan.
  • Sonoda KH; Division of Behavioral Development, Department of System Neuroscience, National Institute for Physiological Sciences, National Institutes of Natural Sciences, Okazaki, Japan.
Diabetologia ; 67(10): 2329-2345, 2024 Oct.
Article em En | MEDLINE | ID: mdl-38977459
ABSTRACT
AIMS/

HYPOTHESIS:

Diabetic retinopathy is characterised by neuroinflammation that drives neuronal and vascular degenerative pathology, which in many individuals can lead to retinal ischaemia and neovascularisation. Infiltrating macrophages and activated retina-resident microglia have been implicated in the progression of diabetic retinopathy, although the distinct roles of these immune cells remain ill-defined. Our aim was to clarify the distinct roles of macrophages/microglia in the pathogenesis of proliferative ischaemic retinopathies.

METHODS:

Murine oxygen-induced retinopathy is commonly used as a model of ischaemia-induced proliferative diabetic retinopathy (PDR). We evaluated the phenotype macrophages/microglia by immunostaining, quantitative real-time RT-PCR (qRT-PCR), flow cytometry and scRNA-seq analysis. In clinical imaging studies of diabetic retinopathy, we used optical coherence tomography (OCT) and OCT angiography.

RESULTS:

Immunostaining, qRT-PCR and flow cytometry showed expression levels of M1-like macrophages/microglia markers (CD80, CD68 and nitric oxide synthase 2) and M2-like macrophages/microglia markers (CD206, CD163 and macrophage scavenger receptor 1) were upregulated in areas of retinal ischaemia and around neo-vessels, respectively. scRNA-seq analysis of the ischaemic retina revealed distinct ischaemia-related clusters of macrophages/microglia that express M1 markers as well as C-C chemokine receptor 2. Inhibition of Rho-kinase (ROCK) suppressed CCL2 expression and reduced CCR2-positive M1-like macrophages/microglia in areas of ischaemia. Furthermore, the area of retinal ischaemia was reduced by suppressing blood macrophage infiltration not only by ROCK inhibitor and monocyte chemoattractant protein-1 antibody but also by GdCl3. Clinical imaging studies of diabetic retinopathy using OCT indicated potential involvement of macrophages/microglia represented by hyperreflective foci in areas of reduced perfusion. CONCLUSIONS/

INTERPRETATION:

These results collectively indicated that heterotypic macrophages/microglia differentially contribute to retinal ischaemia and neovascularisation in retinal vascular diseases including diabetic retinopathy. This adds important new information that could provide a basis for a more targeted, cell-specific therapeutic approach to prevent progression to sight-threatening PDR.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Retina / Microglia / Retinopatia Diabética / Isquemia / Macrófagos Limite: Animals / Humans / Male Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Retina / Microglia / Retinopatia Diabética / Isquemia / Macrófagos Limite: Animals / Humans / Male Idioma: En Ano de publicação: 2024 Tipo de documento: Article